Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2015 Financial Results on May 12, 2015 4/28/15 Eagle Pharmaceuticals to Present at Deutsche Bank 40th Annual Health Care Conference 4/22/15 Teva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for Filing 4/14/15 Eagle Pharmaceuticals Appoints David M. Pernock to Its Board of Directors 4/13/15 Eagle Pharmaceuticals Announces New Patent for Low-Sodium Bendamustine 4/7/15 Eagle Pharmaceuticals to Present at Needham & Company’s 14th Annual Healthcare Conference 4/2/15 Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3/17/15 Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock 3/16/15 FDA Grants Seven Years’ Market Exclusivity to Eagle Pharmaceuticals’ Ryanodex for the Treatment of Malignant Hyperthermia 2/23/15 Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion Product 2/17/15 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Next page Last page
